Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.9.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.9.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.9.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KC.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KC.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KC.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KL.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KL.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KL.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
HC.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.507NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.507NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.507NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.196NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.196NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.196NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.57NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.459NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used